glp-1 inhibitors Receptor Agonist Shortage: Challenges and Solutions in Type 2 Diabetes Care How GLP-1 Receptor Agonists Evolved
Description
J Pers Med 12(3):454 [DOI] [PMC free article] [PubMed] [Google Scholar] 80.Ma X et al (2021) GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
While small-molecule pharmaceuticals and biologics are available to treat patients with UC, approximately one-third of people receiving treatment do not get better
In another study, 73 of 77 participants underwent repeat DaTSPECT imaging at 96 weeks, but no significant differences in striatal binding changes were observed between the exenatide and placebo groups across all regions analyzed [34]
Semaglutide is also an FDA-approved weight loss drug
The glucagon receptor component introduces a theoretical concern about bone density, as glucagon signalling has been associated with increased bone resorption in some preclinical models
[DOI] [PubMed] [Google Scholar] 54.Latif W, Lambrinos KJ, Rodriguez R
